Research - New York, New York, United States
FREZENT Biological Solutions was founded to address the unmet need for novel effective therapies for advanced stage cancer patients. We focus on patients with rare types of head and neck cancer, with a 5-year survival rate less than 50%. Majority of these patients will develop recurrent cancer and succumb to disease within a year. We want to give these people hope by developing a maintenance therapy, an effective medicine that patients can tolerate as a long as they live.
Squarespace ECommerce
Outlook
Typekit
Mobile Friendly